Page 2 - Generic Medicines

IMA opposes NMC move to mandate doctors to prescribe only generic medicines

IMA felt that if the Centre is serious about implementing generic drugs, then it should not give licences to branded drugs at all, and at the same time ensure the quality of generic drugs

Defer implementation of NMC regulations: IMA to govt on generic drugs

The Indian Medical Association (IMA) on Monday demanded deferring the implementation of the National Medical Commission regulations that make it mandatory for doctors to prescribe generic drugs, stating the biggest impediment to such medicines is the uncertainty about their quality. The IMA stated that less than 0.1 per cent of the drugs manufactured in India are tested for quality. "This step should be deferred till the government can assure the quality of all the drugs released into the market. Patient care and safety are not negotiable," the association said in a statement. The National Medical Commission (NMC) in its "regulations relating to professional conduct of registered medical practitioners" stated that all doctors must prescribe generic drugs, failing which they will be penalised and even their licence to practise may be suspended for a period. It also asked doctors to avoid prescribing branded generic drugs. Rather than taking the NMC route the government should take

Big pharma firms shift tack, look to bet on trade generics as volumes dip

It is the fastest growing segment in IPM with a 25% CAGR

Centre-run hospitals asked to prescribe generic medicines only: Mandaviya

The government aims to open 10,000 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) by March to improve the common man's access to generic medicines, Union Health Minister Mansukh Mandaviya told the Lok Sabha on Friday. Till June 30, 9,512 PMBJKs have been opened across the country. The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physician should prescribe drugs with generic names legibly and preferably in capital letters, he said in a written response to a question in the House. The Directorate General of Health Services has directed all Centre-run hospitals to prescribe generic medicines only. Similar instructions also have been issued to all CGHS doctors and wellness centres. Under the free drug initiative of the National Health Mission (NHM), support is provided for provision of essential generic drugs free of cost in public health facilities. In order to promote the PMBJP scheme, the Department of Pharmaceuti

India vigilant, will never compromise on quality of medicines: Mandaviya

Mansukh Mandaviya said that there is 'zero tolerance' for spurious medicines and that 71 companies have been served with show-cause notices

Pharma companies seek price ceiling exemption for low-cost medicines

The industry and the government are on the same page on trade margin rationalisation, however, the industry wants it to be implemented in a phased manner

Zydus Lifesciences gets USFDA nod for generic female hormone in US market

Zydus Lifesciences on Tuesday said it has received approval from the US regulator to market a generic female hormone, which helps reduce symptoms of menopause, in the US market. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Estradiol Transdermal System USP in the American market. Estradiol transdermal system is indicated for prevention of postmenopausal osteoporosis. The company said the drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad in Gujarat. As per the IQVIA sales data, Estradiol Transdermal System had annual sales of USD 1.9 million in the US.

Japan to lower Covid-19 to flu status, further easing rules: PM Kishida

Japanese PM Fumio Kishida announced plans to downgrade the legal status of COVID-19 to the equivalent of seasonal influenza in the spring

Chhattisgarh govt's flagship scheme delivers hefty markdown on medicines

The state government has given priority to the health security of the people, the official said

A stringent patent rule is latest hurdle for India-UK free trade agreement

The draft has also proposed to prohibit pre-grant oppositions, which means that India will not be able to stop challenges to weak/invalid patents until after they have been granted

Lupin gets USFDA approval for Formoterol Fumarate Inhalation Solution

Lupin on Wednesday said it has received approval from the USFDA for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease. The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty's Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement. As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market. Shares of Lupin ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.

Zydus gets USFDA approval to market generic antifungal medication

Zydus Lifesciences on Monday said its subsidiary has received approval from the US health regulator to market antifungal Efinaconazole Topical solution

PM to interact with 'Jan Aushadhi Kendra' owners, beneficiaries on Monday

Prime Minister Modi will interact with Jan Aushadhi kendra owners and beneficiaries of the scheme on March 7 at 12:30 PM via video conferencing, according to the statement

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Lupin alliance partner Concord gets USFDA nod for generic medicine

Concord has received approval from the US Food and Drug Administration (USFDA) to market the drug to prevent organ transplant rejection

Lupin recieves USFDA nod to market generic anthelmintic tablets

According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said

Lupin's partner Concord gets USFDA nod to market generic Myfortic tablet

The product is a generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets in the same strengths, it added

How govt's new rules on drug retailing will make your life safer and better

Making essential drugs easily available is important in a country like India, which has less than one doctor per 1,000 people

Generico devising technology-enabled solutions for chronic diseases

Last week, Generico, which runs a network of pharmacies selling generic drugs, raised $14 million in a Series A funding round, led by venture capital firm Lightbox